- Credit Type: CME
- Credit Amount: 2.00
- Cost: Free
- Release: Jun 5, 2015
- Expires: Sep 12, 2017
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
Professor of Ophthalmology and Visual Sciences
St Louis, MO
Professor of Ophthalmology
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Needs StatementSignificant advances in our knowledge in blinding diseases of the conjunctiva and cornea have opened avenues of translational research that are improving the diagnosis and management of these conditions. Here, we focus on genetic and molecular mechanisms of corneal dystrophies with an emphasis on Fuchs' disease as well as cicatricial conjunctivitis
Target AudiencePhysicians, clinical researchers, optometry students, residents, fellows and any healthcare professional interested in ophthamology
ObjectivesUpon completion of this activity participants will be able to:
1. Discuss molecular mechanisms in the pathogenesis of corneal dystrophies
2. Review diagnosis and management of cicatricial conjunctivitis
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
- Patient care
- Medical knowledge
Faculty DisclosureAndrew J.W. Huang, MD, MPH (Speaker) has relevant financial relationships with commercial interests as follows: Allergan - speaker at Ocular Surface Group - Honararium
No Other speakers, planners or content reviewers have any relevant financial relationships to disclose.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.